Serum gamma-glutamyl transpeptidase/albumin ratio in patients with acute myeloid leukemia: a new perspective on prognostic assessment

We propose GAR as a prognostic biomarker in AML cases, providing a new perspective for prognostic assessment.

Authors

Institutions

Publication Details

Journal
Hematology
Published
2026-01-06
DOI
https://doi.org/10.1080/16078454.2025.2611526
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum gamma-glutamyl transpeptidase/albumin ratio in patients with acute myeloid leukemia: a new perspective on prognostic assessment

Jie Shi, N Liu, P Wang, Min Ji Song et al.
Hematology
Inflammatory Biomarkers in Disease Prognosis
article

Serum gamma-glutamyl transpeptidase/albumin ratio in patients with acute myeloid leukemia: a new perspective on prognostic assessment

Jie Shi, N Liu, P Wang, Min Ji Song, M. C. Wei, Xiaoman Sun
article en

Abstract

We propose GAR as a prognostic biomarker in AML cases, providing a new perspective for prognostic assessment.

HematologyVol. 31(1)
Henan Provincial People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 95%
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum gamma-glutamyl transpeptidase/albumin ratio in patients with acute myeloid leukemia: a new perspective on prognostic assessment — Jie Shi, N Liu, et al. · Hematology (2026) | TGRS Research Map | TGRS